Whole‐Blood Interleukin‐18 Level during Early HIV‐1 Infection Is Associated with Reduced CXCR4 Coreceptor Expression and Interferon‐γ Levels
Author(s) -
Carrie A. Sailer,
Gregory B. Pott,
Charles A. Dinarello,
Samantha Ma Whinney,
Jeri E. Forster,
Jacqueline K. LarsonDuran,
Alan Landay,
Lena AlHarthi,
Robert T. Schooley,
Constance A. Benson,
Franklyn N. Judson,
Melanie Thompson,
Frank J. Palella,
Leland Shapiro
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/511435
Subject(s) - human immunodeficiency virus (hiv) , interferon , immunology , cxcr4 , virology , biology , interleukin , medicine , cytokine , microbiology and biotechnology , immune system , chemokine
Interleukin (IL)-18 generates T helper 1-type immunity and inhibits human immunodeficiency virus type 1 (HIV-1) in primary cells in vitro. Because IL-18 may participate in HIV-1 containment, whole-blood IL-18 levels were measured in 20 healthy control subjects and longitudinally in 28 subjects with early HIV-1 infection. Compared with those in control subjects, IL-18 levels were higher during early HIV-1 infection, and IL-18 levels predicted reduced CXCR4 HIV-1 coreceptor expression and diminished interferon (IFN)- gamma levels. By contrast, a direct association between IL-18 and IFN- gamma levels was observed in blood stimulated with lipopolysaccharide. During early HIV-1 infection, IL-18 may regulate HIV-1 coreceptor expression and have antiretroviral activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom